We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Allyson Byrd - Senior Scientist, Cancer Immunology

Allyson Byrd

Senior Scientist, Cancer Immunology

"One of my favorite parts about working at Genentech has been seeing results from my own team’s analyzes being used to drive clinical decisions. The fulfillment of knowing you’re helping patients is so much greater than any paper acceptance."
Years at Genentech
Publications at Genentech
Awards & Honors

While my experience with microbes began in the skin, at Genentech, I shifted my focus inward to our gut microbiome. As a scientist in Cancer Immunology, my group leverages clinical samples to understand how gut microbes impact systemic anti-tumor immunity and response to checkpoint inhibitors. By unlocking this new set of variables, we hope to discover new microbial biomarkers and unconventional targets for drug development.

Featured Publication

Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers

J Exp Med (2021) 218 (1): e20200606.

Byrd et al.

Biogeography and individuality shape function in the human skin metagenome

Nature 514 (7520), 59-64

J Oh, AL Byrd, C Deming, S Conlan, B Barnabas, R Blakesley, G Bouffard, ...

Temporal Stability of the Human Skin Microbiome

Cell 165 (4), 854-866

J Oh, AL Byrd, M Park, HH Kong, JA Segre, ...

Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis

Science translational medicine 9 (397)

AL Byrd, C Deming, SKB Cassidy, OJ Harrison, WI Ng, S Conlan, ...

Adapting Koch's postulates

Science 351 (6270), 224-226

AL Byrd, JA Segre